Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company
-
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
-
22nd Century to Participate in Cowen and Roth Capital Investor Conferences in November 2021
-
22nd Century Group Reports Business Highlights and Financial Results for the Third Quarter 2021
-
22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
-
Cowen Starts 22nd Century Group (XXII) at Outperform
-
22nd Century Announces Closing of $40 Million Common Stock Registered Direct Offering
-
22nd Century Group (XXII) Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
-
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
-
22nd Century Group (XXII) Announces $40 Million Common Stock Registered Direct Offering
-
22nd Century Announces $40 Million Common Stock Registered Direct Offering
-
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
-
Pre-Open Stock Movers 10/16: (TRXC) (RT) (EXEL) Higher; (AMPE) (ADBE) (ISRG) Lower (more...)
-
Pre-Open Movers 10/09: (CLNT) (TROV) (GEVO) Higher; (XXII) (KTWO) (PTCT) Lower (more...)

